The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion

Stem Cells and Development

Volumn 14, Issue 5, 2005, Pages 564-575

  Von Drygalski, A ^a   Savatski, L ^a   Eastwood, D ^b   Klein, J ^b   Adamson, John W ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KAPLAN MEIER METHOD; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CELL LINEAGE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-3; LEUKOCYTES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMALIA; MURINAE;

EID: 28844496673     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2005.14.564     Document Type: Article

References (65)

1. Rubinstein P, C Carrier, A Scaradavou, J Kurtzberg, J Adamson, AR Migliaccio, RL Berkowitz, M Cabbad, LN Dobrila, PE Taylor, R Rosenfield, and CE Stevens. (1998). Outcomes of 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339:1565-1577.
2. Migliaccio AR, JW Adamson, CE Stevens, NL Dobrila, CM Carrier, and P Rubinstein. (2000). Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 96:2717-2722.
3. + cells: effects of Flt3-L and MIP-1α on in vitro expansion of hematopoietic progenitor cells. Haematologica 84:675-682.
4. De Felice L, T Di Pucchio, MG Mascolo, F Agostini, M Breccia, C Gugliemli, MR Ricciardi, A Tafuri, M Screnci, F Mandelli, and W Arcese. (1999). Flt3LP3 induces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures. Br J Haematol 106:133-141.
5. van den Oudenrijn S, M de Haas, J Calafat, CE van der Schoot, and AE von dem Borne. (1999). A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes. Br J Haematol 106:553-563.
6. Giarratana MC, L Kobari, TM Neildez, H Firat, S Bouchet, M Lopez, NC Gorin, D Thierry, and L Douay. (1999). Cell culture bags allow a large extent of ex vivo expansion of LTC-IC and functional mature cells which can subsequently be frozen: interest for a large-scale clinical application. Bone Marrow Transplant 22:707-715.
7. Koller MR, I Manchel, RJ Maher, KL Goltry, RD Armstrong, and AK Smith. (1998). Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 21:653-663.
8. Mobest D, R Mertelsmann, and R Henschler. (1998). Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells. Biotechnol Bioeng 60:341-347.
9. Paquette RL, E Gonzales, R Yoshimura, L Tran, R Choi, G Baldwin, DJ Slamon, and J Glaspy. (1998). Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free media. J Hematother 7:481-491.
10. + cells. (1997). Committed precursor expansion does not affect immature hematopoietic progenitors. J Hematother 6:151-158.
11. + progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Exp Hematol 25:1125-1139.
12. + early megakaryocytic marrow cells cultured on normal osteoblasts. Stem Cells 17:92-99.
13. + mobilized peripheral blood stem cells. Blood 91:111-117.
14. Brandt JE, AH Galy, KM Luens, M Travis, J Young, J Tong, S Chen, TA Davis, KP Lee, BP Chen, R Tushinski, and R Hoffman. (1998). Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Exp Hematol 26:950-961.
15. Piacibello W, F Sanavio, L Garetto, A Severino, A Dane. L Gammaitoni, and M Aglietta. (1998). Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 12:718-727.
16. + cells into the myeloid lineage. Blood 80:1405-1412.
17. + cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Blood Cells 20:436-445.
18. Foguenne J, S Huygen, R Greimers, Y Beguin, and A Gothot. (2005). Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion. Haematologica 90:445-451.
19. Huygen S, O Giet, V Artisien, I Di Stefano, Y Beguin, and A Gothot. (2002). Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture. Blood 100:2744-2752.
20. Szilvassy SJ, TE Meyerrose, PL Ragland, and B Grimes. (2001). Homing and engraftment defects in ex vivo expanded murine hematopoietic cells are associated with downregulation of beta I integrin. Exp Hematol 29:1494-1502.
21. Muench MO, MT Firpo, and MAS Moore. (1993). Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without loss of stem cell lineage and proliferative potential. Blood 12:3463-3473.
22. Ratajczak MZ, J Ratajczak, B Machalinski, R Mick, and AM Gewirtz. (1998). In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopenia. Blood 91:353-359.
23. Albella B, JC Segovia, G Guenecha, IB Pragnell, and JA Bueren. (1999). Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11. Transplantation 67:1348-1357.
24. Holyoake TL, MG Freshney, L McNair, AN Parker, PJ McKay, WP Steard, E Fitzsimons, GJ Graham, and IB Pragnell. (1996). Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant bone marrow. Blood 87:4589-4595.
25. Piacibello W, F Sanavio, L Garetto, A Severino, D Bergandi, J Ferrario, F Fagioli, M Berger, and M Aglietta. (1997). Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89:2644-2653.
26. Muench OM, and MAS Moore. (1992). Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors. Exp Hematol 20:611-618.
27. Li K, CK Li, CK Chuen, KS Tsang, TF Fok, AE James, SM Lee, MM Shing, KW Chik, and PM Yuen. (2005). Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy. Eur J Haematol 74:128-135.
28. Kawano Y, M Kobune, M Yamaguchi, K Nakamura, Y Ito, K Sasaki, S Takahashi, T Nakamura, H Chiba, T Sato, T Matsunaga, H Azuma, K Ikebuchi, H Ikeda, J Kato, Y Niitsu, and H Hamada. (2003). Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood 101:532-540.
29. Berger M, F Fagioli, W Piacibello, F Sanavio, K Mareschi, E Biasin, S Bruno, L Gammaitoni, M Gunetti, F Nesi, E Madon, and M Aglietta. (2002). Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study. Bone Marrow Transplant 29:443-448.
30. Lam AC, K Li, XB Zhang, CK Li, TF Fok, AM Chang, AE James, KS Tsang, and PM Yuen. (2001) Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used: and engraftment in NOD/SCID mice. Transfusion 41:1567-1576.
31. Peters SO, EL Kittler, HS Ramshaw, and PJ Quesenberry. (1996). Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30-37.
32. Traycoff CM, K Cornetta, MC Yoder, A Davidson, and EF Srour. (1996). Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hematol 24:299-306.
33. Dick JE, M Bhatia, O Gan, U Kapp, and JC Wang. (1997). Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 15:199-203.
34. Bonnet D, M Bhatia, JC Wang, U Kapp, and JE Dick. (1999). Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant 23:203-209.
35. + cord blood cells after ex vivo expansion:evidence for the amplification and self-renewal of repopulating stem cells. Blood 93:3736-3749.
36. Bathia M, D Bonnet, U Kapp, JC Wang, B Murdoch, and JE Dick. (1997). Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 186:619-624.
37. + blood progenitor cells. Stem Cells 17:152-161.
38. Albella B, JC Segovia, G Guenecha, IB Pragnell, and JA Bueren. (1999). Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11. Transplantation 67:1348-1357.
39. + cord blood cells. Blood 93:1097-1105.
40. Von Drygalski A, G Alespeiti, L Ren, and JW Adamson. (2004). Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev 13:101-111.
41. Nolta A, MB Hanley, and D Kohn. (1994). Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 10:3041-3051.
42. + cell population from cord blood vs. adult marrow. Exp Hematol 23:1289-1295.
43. Kobayashi M, JH Laver, SD Lyman, T Kato, H Miyazaki, and M Ogawa. (1997). Thrombopoietin, steel factor and the ligand for flt3/flk2 interact to stimulate the proliferation of human hematopoietic progenitors in culture. Int J Hematol 66:423-434.
44. + cord blood cells in the presence of recombinant human stem cell factor. Blood 79:2620-2627.
45. Rocha V, M Labopin, G Sanz et al. (2004). Outcomes after transplantation of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276-2285.
46. Laughlin MJ, M Eapen, P Rubinstein et al. (2004). Outcomes after tranplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265-2275.
47. Sanz M. (2004). Cord-blood transplantation in patients with leukemia-a real alternative for adults (editorial) N Engl J Med 351:2328-2330.
48. Knobel KM, MA McNally, AE Berson, D Rood, K Chen, L Kilinski, K Tran, TB Okarma, and JS Lebkowski. (1994). Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: differential activity of cultured bone marrow and enriched stem cell populations. Exp Hematol 22:1227-1235.
49. Harrison DE, RK Zhong, CT Jordan, IR Lemischka, and CM Astle. (1997). Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp Hematol 25:293-297.
50. Zhong RK, CM Astle, and DE Harrison. (1996). Distinct developmental patterns of short-term and long-term functioning lymphoid and myeloid precursors defined by competitive limiting dilution analysis in vivo. J Immunol. 157:138-145.
51. + cells after allogeneic bone marrow transplantation. J Hematother Stem Cell Res. 11:321-326.
52. + hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J Clin Apheresis 16:67-73.
53. + progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81:2579-2584.
54. Alcorn MJ, TL Holyoake, L Richmond, C Pearson, E Farrell, B Kyle, DJ Dunlop, E Fitzsimons, WP Steward, IB Pragnell, and IM Franklin. (1996). CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol. 14:1839-1847.
55. McNiece I, R Jones, SI Bearman, P Cagnoni, Y Nieto, W Franklin, J Ryder, A Steele, J Stoltz, P Russell, J McDermitt, C Hogan, J Murphy, and EJ Shpall. (2000). Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 96:3001-3007.
56. Reichle A, M Zaiss, G Rothe, G Schmitz, and R Andreesen. (2003). Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells. Bone Marrow Transplant 32:299-305.
57. Stiff P, B Chen, W Franklin, D Oldenberg, E Hsi, R Bayer, E Shpall, J Douville, R Mandalam, D Malhotra, T Muller, RD Armstrong, and A Smith. (2000). Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 95:2169-2174.
58. Decaudin D, JM Vantelon, JH Bourhis, F Farace, ML Bonnet, M Guillier, N Greissenger, MC Marracho, S Assari, AL Bennaceur, F Nemati, J Michon, AG Turhan, and C Boccaccio. (2004). Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma. Bone Marrow Transplant 34:1089-1093.
59. Jaroscak J, K Goltry, A Smith, B Waters-Pick, PL Martin, TA Driscoll, R Howrey, N Chao, J Douville, S Burhop, P Fu, and J Kurtzberg. (2003) Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101:5061-5067.
60. Shpall EJ, R Quinones, R Giller, C Zeng, AE Baron, RB Jones, SI Bearman, Y Nieto, B Freed, N Madinger, CJ Hogan, V Slat-Vasquez, P Russell, B Blunk, D Schissel, E Hild, J Malcolm, W Ward, and IK McNiece. (2002). Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8:368-376.
61. Reya T, AW Duncan, L Ailles, J Domen, D Scherer, K Willert, L Hintz, R Nusse, and I Weissman. (2003). A role for Wnt signaling in self-renewal of haematopoietic stem cells. Nature 423:409-414.
62. Willert K, JD Brown, E Danenberg, A Duncan, I Weissman, T Reya, J Yates, and R Nusse. (2003). Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448-452.
63. Murdoch B, K Chadwick, M Martin, F Shojaei, K Shah, L Gallacher, R Moon, and M Bathia. (2002). Wnt-5a augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc Natl Acad Sci USA 100:3422-3427.
64. Lessard J and G Sauvageau. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-260.
65. Park I, D Quian, M Kiel, M Becker, M Pihalja, I Weissman, S Morrison, and M Clarke. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302-305.